This statistic shows the research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019, in million euros. The group spent nearly 210 million euros in research and development in 2016. An increasing figure over the years as Ipsen spent more than 385 million euros in R&D in 2019.
Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Total equity of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
- Basic Statistic Market share of generics in European countries 2021
About the region
10
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic Top global companies by orphan drug revenues 2022
- Basic Statistic Top drugs based on projected 2024 global sales
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
Selected statistics
6
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Basic Statistic Members of EFPIA's pharmaceutical production value 1990-2022
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic R&D expenses of selected Chinese pharma companies 2021-2022
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Mexico: pharma industry market value 2008-2016
- Premium Statistic Pharma market value in Colombia 2008-2021
Related statistics
10
- Basic Statistic Ipsen group sales 2019, by therapeutic area
- Basic Statistic Medication sales of the Ipsen Group 2019
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Total revenue of the French drug market worldwide 2010-2018
- Premium Statistic Number of companies in the pharmaceutical industry in France 1970-2018
- Premium Statistic Chemical peel facial rejuvenation market size worldwide from 2016-2026
- Basic Statistic Opioid-related inpatient stays under Medicare U.S. 2010 and 2015, by state
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Basic Statistic Average cost of hospital per day by country 2015
Further related statistics
10
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co cash dividends declared 2006-2023
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Merck & Co cash dividends declared 2006-2023
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Ipsen. (February 13, 2020). Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved April 28, 2024, from https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/
Ipsen. "Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed April 28, 2024. https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/
Ipsen. (2020). Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: April 28, 2024. https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/
Ipsen. "Research and Development Expenditure of The French Pharmaceutical Group Ipsen from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/
Ipsen, Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/ (last visited April 28, 2024)
Research and development expenditure of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1072771/ipsen-research-development-expenditure-french-company/